Home > Insider Trading > Filing (0001127602-24-006253)

Filing Details

Accession Number:: 0001127602-24-006253
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-02-22 15:05:42
Reporting Period:: 2024-02-21

Accepted Time:: 2024-02-22 15:05:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
920148	Laboratory Corp Of America Holdings	LH	Services-Medical Laboratories (8071)	133757370

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1222831	A Glenn Eisenberg	531 South Spring Street Burlington NC 27215	Chief Financial Officer, Evp	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-02-21	14,054	$163.63	58,099	No	4	M	Direct
Common Stock	Disposition	2024-02-21	18,379	$215.37	39,720	No	4	S	Direct
Common Stock	Disposition	2024-02-21	7,907	$215.68	31,813	No	4	S	Direct
Common Stock	Disposition	2024-02-21	6,665	$217.52	25,148	No	4	S	Direct
Common Stock	Disposition	2024-02-21	1,553	$217.98	23,595	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified Stock Options	Disposition	2024-02-21	14,054	$0.00	14,054	$163.63

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2021-02-04	2030-02-03	No	4	M	Direct

Footnotes

The price of $215.3661 per share represents a weighted average of sales prices ranging from $214.80 to $215.79 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
The price of $215.6759 per share represents a weighted average of sales prices ranging from $215.80 to $216.66 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
The price of $217.5205 per share represents a weighted average of sales prices ranging from $216.87 to $217.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
The price of $217.9842 per share represents a weighted average of sales prices ranging from $217.89 to $218.075 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.
The option vested in three equal annual installments beginning on the date reflected in this column.